Kymera TherapeuticsKYMR
那斯達克 · USD
87.81
-2.08
(-2.31%)
收盤 12/12 04:59 (UTC+8)
盤後
91.17
+3.36
(+3.83%)
12/12 04:59 (UTC+8)
Kymera TherapeuticsKYMR
87.81
-2.08
(-2.31%)
財務數據
損益表
- 0.17
- 0.05
- 0.48
- 0.10
- 0.26
- 0.04
- 0.07
- 0.22
- 0.11
- 0.03
- 74.45
- -71.37
- 912.80
- -78.52
- 149.34
- -85.42
- 97.65
- 198.89
- -48.07
- -75.91
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 2,765 | 11,476 | 22,100 | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 2,765 | 11,476 | 22,100 | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 |
營業費用 | 95,285 | 96,033 | 96,526 | 88,149 | 75,865 | 76,575 | 68,118 | 67,197 | 62,237 | 59,896 |
研發費用 | 74,094 | 78,388 | 80,255 | 71,817 | 60,410 | 59,202 | 48,819 | 52,970 | 48,117 | 45,767 |
推銷及管理費用 | 17,336 | 17,645 | 16,271 | 16,332 | 15,455 | 17,373 | 14,374 | 14,227 | 14,120 | 14,129 |
非經常性項目費用 | 3,855 | - | - | - | - | - | 4,925 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -92,520 | -84,557 | -74,426 | -80,755 | -72,124 | -50,925 | -57,831 | -19,312 | -57,509 | -43,383 |
其他收入及費用 | 10,445 | 8,051 | 8,917 | 10,062 | 9,696 | 8,925 | 9,343 | 4,996 | 4,683 | 4,632 |
利息費用 | 100 | 108 | 72 | 59 | 59 | 62 | 69 | 52 | 41 | 48 |
稅前純益 | -82,175 | -76,614 | -65,581 | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -82,175 | -76,614 | -65,581 | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 |
基本每股稅後盈餘(元) | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 |
稀釋每股稅後盈餘(元) | -0.94 | -0.95 | -0.82 | -0.89 | -0.83 | -0.57 | -0.69 | -0.25 | -0.90 | -0.67 |
基本平均股數(千股) | 87300.00 | 80449.00 | 80146.00 | 79987.00 | 76125.00 | 73059.00 | 70770.00 | 58521.00 | 58421.00 | 58326.00 |
稀釋平均股數(千股) | 87300.00 | 80449.00 | 80146.00 | 79987.00 | 76125.00 | 73059.00 | 70770.00 | 58521.00 | 58421.00 | 58326.00 |
還原基本每股稅後盈餘(元) | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 |
還原稀釋每股稅後盈餘(元) | -0.94 | -0.95 | -0.82 | -0.89 | -0.83 | -0.57 | -0.69 | -0.25 | -0.90 | -0.67 |
還原基本平均股數(千股) | 87,300 | 80,449 | 80,146 | 79,987 | 76,125 | 73,059 | 70,770 | 58,521 | 58,421 | 58,326 |
還原稀釋平均股數(千股) | 87,300 | 80,449 | 80,146 | 79,987 | 76,125 | 73,059 | 70,770 | 58,521 | 58,421 | 58,326 |
EBITDA(千元) | -79,926 | -74,422 | -63,461 | -68,706 | -60,441 | -40,062 | -47,027 | -13,425 | -51,931 | -37,851 |